Phase 4 Completed N=67 Randomized Treatment

Evaluation of Biocleanse Allografts For ACL Reconstruction

Anterior Cruciate Ligament Tear

Source: ClinicalTrials.gov NCT00187876 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Mar 2014

Primary outcomePrimary: International Knee Documentation Committee (IKDC) Form — 89; 88 score

Summary

The purpose of this study is to determine the efficacy of patellar tendon allografts that have undergone the BioCleanse™ process.

Outcome Measures

Outcome	Result	p-value
PRIMARY International Knee Documentation Committee (IKDC) Form	89; 88	—

Eligibility Criteria

Inclusion Criteria

ACL reconstruction

Exclusion Criteria

none

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00187876). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.